Halozyme Therapeutics | DEBITO



Debt Cambiamento Data
Acadia Pharmaceuticals USD 0 0 2024-12
Agios Pharmaceuticals USD 0 0 2024-12
Alnylam Pharmaceuticals USD 1.02B 967K 2024-12
Amarin USD 0 0 2024-09
Amgen USD 60.1B 299M 2024-12
Baxter International USD 13.13B 191M 2024-12
Cytokinetics USD 657.12M 1.1M 2024-12
DBV Technologies USD 0 0 2024-09
Eli Lilly USD 33.64B 2.52B 2024-12
Halozyme Therapeutics USD 1.51B 1.64M 2024-12
Indivior 284M 3M 2024-09
Ionis Pharmaceuticals USD 1.25B 32.8M 2024-12
MannKind USD 289.64M 191.38M 2024-12
Pfizer USD 64.35B 3.35B 2024-12
United Therapeutics USD 300M 100M 2024-12



Halozyme Therapeutics DEBITO - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.